Supported by

Catalogue of collaboration profiles

back to list

Xeroshield Ltd.

Wallace Building, Roslin BioCentre
ZIP Code
EH25 9PP
United Kingdom

Company Profile:
Formed in 2005, based at Roslin BioCentre near Edinburgh, Scotland. Business model: Look for alternatives to conventional insecticides as insect control methods, working with people from very different disciplines to develop novel technologies funded by public sector grants or private sponsorship. Carry out proof of concept studies, look for licensing deal with manufacturers/distributors. Current links with Napier University, University of Leeds, Cambridge University, Scottish Crop Research Institute (UK); Universidad de Antioquia (Colombia); Universidade Federal de Rio Grande do Norte, Universidade Federal de Piaui (Brazil); Charles Darwin University (Australia). Extensive experience of field-based entomological research, particularly in Latin America but also Bulgaria, Tunisia, Thailand and Australia.

Development of innovative insect pest control technologies

What we offer:
We are looking for potential partners in projects to help develop our technologies, and/or manufacture them under licence. We have extensive experience in several aspects of insect pest control, related both to public health and agricultural problems. We are fluent in both Spanish and Portuguese but interested in considering potential collaborations throughout Europe and beyond. Our technologies all offer alternatives to conventional chemical insecticide use. We are open to new ideas from any source.

What are we looking for:
We are looking for partnerships with anyone interested in finding solutions to insect pest problems that do not involve the application of conventional chemical insecticides. These partnerships may involve development of existing ideas, assistance in developing new ideas by the partner, manufacture and distribution fo technologies or any related fields (e.g. promotion and marketing)

Collaboration sought:
  • Research & Development
  • Technical Co-operation
  • Joint Venture Agreement
  • Manufacturing Agreement
  • Licence
  • Commercial Agreement


Bruce Alexander

Managing Director

back to list


Enterprise Europe ScotlandAboleo LtdAccuro BiologicsAlliance BootsBeta TechnologyBitWiseFW Medical LLPInnova Partnerships LtdInterface-The knowledge connection for businessMarks and Clerk LLPMcClure Naismith LLPThe Medical Device Company LtdQuantics Consulting LtdScottish Health InnovationsPharmalinksSistemic LtdStrathclyde Institute of Medical DevicesSynthetic Nanomachines LtdTissue SolutionsUniversity of AberdeenEllis IP LtdPharmacells LtdCeltic CatalystsPharmaceutical eConsultingWeatherologyControlled TherapeuticsSphere Fluidics LimitedHighland Clinical Research FacilityMoorfields PharmaceuticalsEdinburgh Science Trianglebeocarta LtdRostiShore DesignPomBioTech GmbHIMG Innovations-Management  GmbH/ Enterprise Europe NetworkThe Eurotactics ConsultancyIBA GmbHSGS Life Science ServicesOnorach  ClinicalWideblueEnterprise Europe YorkshireAptuit ConsultingMosaigen/Endeavour CapitalEscubed LtdEulysis Ltd.Raumedic LtdCatalent Pharma SolutionsEscubed LtdUniversity of Aberdeen Research and InnovationSPRI - Basque Enterprise Europe NetworkLicentia LtdTake The WindRoslin CellabMoredun ScientificEnterprise Europe East of EnglandAvantiCell ScienceXeroshield Ltd.ImmunoSolv LimitedLeoben Research LimitedPRAXI / HELP-FORWARD Network &The Hellenic BioClusterEMBIO Diagnostics Ltd

© 2010 ConVerve GmbH | all rights reserved